Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid

Yi Bi,Jinyi Xu,Fei Sun,Xiaoming Wu,Wencai Ye,Yijun Sun,QingGuo Meng,Wenwen Huang
IF: 2
2013-01-01
Records of Natural Products
Abstract:A novel series of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid (1) were prepared and tested in vitro against five cell lines: A549 (human lung carcinoma), BEL-7402 (human hepatoma), SF-763 (human cerebroma), B16 (mice melanoma) and HL-60 (human leukaemia). Within this series of compounds, 4a (IC50=21.08 mu M in SF-763, IC50=21.63 mu M in HL-60), 4b (IC50=28.45 mu M in HL-60, IC50=29.32 mu M in BEL-7402) and 6g (IC50=26.09 mu M in BEL-7402, IC50=22.65 mu M in HL-60) have the more potent cytotoxic activity than lead compound 1. The preliminary structure-activity relationship analysis of the C-28 amide derivatives is also discussed.
What problem does this paper attempt to address?